Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal versus IV/IM ketamine for paediatric emergency department procedural sedation
ACTRN12616000399493Phase 3Not yet recruiting
- Sponsor
- Townsville Hospital and Health Service
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine (2 arms), sponsored by Townsville Hospital and Health Service. Primary endpoint: Sedation efficacy/adequacy for procedure. Planned start Aug 2016; status: not yet recruiting.
02
Drugs
ketamine
Beyond the preview
Go deeper on ACTRN12616000399493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000399493.